Georges Thiry

Title: The Innovations of Georges Thiry

Introduction

Georges Thiry is a notable inventor based in New York, NY (US). He has made significant contributions to the field of virology, particularly in the development of vaccines for rotavirus. With a total of two patents to his name, Thiry's work has the potential to impact public health positively.

Latest Patents

Thiry's latest patents include the invention of a homogeneous attenuated human rotavirus population. This invention provides an attenuated rotavirus population comprising a single variant or substantially a single variant, defined by a nucleotide sequence encoding at least one of the major viral proteins designated as VP4 and VP7. Specifically, this rotavirus population is designated as P43. Additionally, he has developed a novel formulation for a rotavirus vaccine, which is presented in the form of a quick-dissolving tablet for immediate dissolution when placed on the tongue. Another patent focuses on the immunogenic composition of a homogeneous live attenuated human rotavirus population, reiterating the significance of the P43 variant and the innovative tablet formulation.

Career Highlights

Georges Thiry is associated with GlaxoSmithKline Biologicals SA, a leading company in the pharmaceutical and vaccine industry. His work at this organization has allowed him to contribute to groundbreaking research and development in vaccine technology.

Collaborations

Thiry has collaborated with notable colleagues, including Brigitte Desiree Alberte Colau and Francoise Denamur. These collaborations have likely enhanced the quality and impact of his research.

Conclusion

Georges Thiry's contributions to vaccine development, particularly in the area of rotavirus, demonstrate his commitment to advancing public health through innovation. His patents reflect a significant step forward in the fight against viral infections.